Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app ease the back pain burden on nurses?

NCT ID NCT07785804

Disease control Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app called SelfBack can reduce disability from low back pain in healthcare workers like nurses and assistants. The app creates personalized weekly plans with exercises, walking goals, and education based on user input and step data. Participants are assigned to either use the app alongside usual care or receive usual care alone. The study measures changes in back-pain-related disability over three months, with follow-ups up to a year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SelfBack app, a smartphone-based digital decision-support system providing personalized weekly self-management plans (exercises, walking goals, education)
What this could lead to
If effective, the app could offer a scalable, low-cost way to help healthcare workers manage and prevent low back pain, reducing disability and sick leave.
What could go wrong
This is a non-randomized trial, so results may be influenced by differences between groups. The app's benefits beyond usual care are uncertain, and adherence may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Currently working as a nurse, assistant nurse - logistical assistance in one of the selected units of the Universitair Ziekenhuis (UZ) Brussel, Valida or Inkendaal * Presence or not of LBP of any duration * Age: ≥18 years * Own and regularly use a smartphone (with at least Android 7.0 or iOS11.0) with internet access (Wi-Fi and/or mobile data) * Have a working email address and have access to a computer with internet access to complete questionnaires in a web browser. Exclusion Criteria: * Unable to speak, read or understand the national languages (Dutch/French/German) nor English * Presence of red flags as described in the KCE LBP guidelines * Work leave for medical reasons of more than 3 consecutive days during the last 6 months * Cognitive impairments or learning disabilities limiting participation * Mental or physical illness or condition limiting participation * Inability to take part in exercise or physical activity * Pregnancy * Previous back surgery * Ongoing participation in other research trials for LBP management

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Uz Brussel

    Brussels, Brussels Capital, 1090, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.